Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, developing as a continuum, and progressing from the initial insult (underlying …

Successful resuscitation from cardiac arrest results in a post–cardiac arrest syndrome, which
can evolve in the days to weeks after return of sustained circulation. The components of post …

The first line of defense in innate immunity is provided by cellular and humoral mediators.
Pentraxins are a superfamily of phylogenetically conserved humoral mediators of innate …

Background Cardiogenic shock (CS) is a common cause of morbidity and mortality in
cardiac intensive care units (CICUs), even in the contemporary era. Main text Although …

BACKGROUND: Patients presenting with cardiogenic shock (CS) are at risk of developing
mixed shock (MS), characterized by distributive-inflammatory phenotype. However, no …

Recent clinical and research efforts in cardiogenic shock (CS) have largely focussed on the
restoration of the low cardiac output state that is the conditio sine qua non of the clinical …

Cardiogenic shock (CS) is characterized by peripheral vasoconstriction and critical end-
organ damage caused by inadequate cardiac output (CO) and oxygen delivery (DO2)[1]. In …

Abstract Background: Procalcitonin (PCT), an inflammatory blood biomarker, is well studied
in infectious diseases. Its prognostic value in unselected emergency department (ED) …

Patients with cardiogenic shock (CS) display systemic inflammation and a high rate of
infections, suggesting important immune disturbances. To explore the immune response to …

Purpose The purpose of our study was to characterize the epidemiology of blood stream
infection (BSI) in adult extracorporeal membrane oxygenation (ECMO) patients at a single …